DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice
Diabetic nephropathy (DN) is the main leading cause of chronic kidney disease worldwide. Although remarkable therapeutic advances have been made during the last few years, there still exists a high residual risk of disease progression to end-stage renal failure. To further understand the pathogenesis of tissue injury in this disease, by means of the Next-Generation Sequencing, we have studied the microRNA (miRNA) differential expression pattern in kidneys of Black and Tan Brachyury (BTBR) ob/ob (leptin deficiency mutation) mouse. This experimental model of type 2 diabetes and obesity recapitulates the key histopathological features described in advanced human DN and therefore can provide potential useful translational information. The miRNA-seq analysis, performed in the renal cortex of 22-week-old BTBR ob/ob mice, pointed out a set of 99 miRNAs significantly increased compared to non-diabetic, non-obese control mice of the same age, whereas no miRNAs were significantly decreased. Among them, miR-802, miR-34a, miR-132, miR-101a, and mir-379 were the most upregulated ones in diabetic kidneys. The in silico prediction of potential targets for the 99 miRNAs highlighted inflammatory and immune processes, as the most relevant pathways, emphasizing the importance of inflammation in the pathogenesis of kidney damage associated to diabetes. Other identified top canonical pathways were adipogenesis (related with ectopic fatty accumulation), necroptosis (an inflammatory and regulated form of cell death), and epithelial-to-mesenchymal transition, the latter supporting the importance of tubular cell phenotype changes in the pathogenesis of DN. These findings could facilitate a better understanding of this complex disease and potentially open new avenues for the design of novel therapeutic approaches to DN., This work was supported by grants from the Instituto de Salud
Carlos III (ISCIII) and Fondos FEDER European Union (PI17/
00119, PI17/01495, PI17/00130, PI20/00140, PI19/00184,
PI20/00639, PI20/00487, PI20/00375, DTS20/00083, and
DTS19/00093), Red de Investigación Renal REDINREN:
RD16/0009 to MR-O (RD16/0009/0003) and to CL-L
(RD16/0009/0020), Sociedad Española de Nefrología,
“NOVELREN-CM: Enfermedad renal crónica: nuevas
Estrategias para la prevención, Diagnóstico y tratamiento”
(B2017/BMD-3751 to MR-O), “Convocatoria Dinamización
Europa Investigación 2019” MINECO (EIN 2019-103294 to
MR-O), Innovation programme under the Marie SkłodowskaCurie grant of the European Union’s Horizon 2020
(IMProve-PD ID: 812699 to MR-O), Spanish Biomedical
Research Centre in Cardiovascular Diseases (CIBERCV),
Spanish Ministry of Science and Innovation (RYC-2017-
22369), Consejería de Salud y Familias-FEDER, Junta de
Andalucía (PIGE-0052-2020 to JM), and Gobierno de Chile
(S-2020-05 VIDCA-UACh to CL). RICORS program to
RICORS2040 (KIDNEY DISEASE) RD21/0005/0002 to MRO; RD21/0005/0017 to CL-L.
Project:
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI17-00119
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI17-01495
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (ISCIII) PI17-00130
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI20-00140
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI19-00184
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI20-00487
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) PI20-00375
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) DTS20-00083
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) DTS19-00093
,
ISCIII / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII) METABOLITOS MICROBIANOS COMO MODULADORES DE LAS DINAMICAS EPIGENETICAS EN EL DAÑO RENAL: DESARROLLO PRE-CLINICO DE UNA TERAPIA"POST-BIOTICA". Código proyecto: PI20
,
MINECO RD16-0009-0003
,
MINECO RD16-0009-0020
View at: http://hdl.handle.net/10261/370026